Inventor
Peter C. Gray
Inventor
Encinitas, CA, US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
A61KPreparations for medical, dental or toiletry purposes20%
G01NInvestigating or analysing materials by determining their chemical or physical properties20%
PatentTitleYear
9,546,210'Cripto antagonism of activin and TGF-b signaling'20177,820,620'Cripto antagonism of activin and TGF-b signaling'20107,575,751'Activin-A mutants'20097,455,839'Method of inhibiting the formation of inhibin/betaglycan complexes with an anti-betaglycan antibody'20086,692,744'Betaglycan as an inhibin receptor and uses thereof'2004Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2004–2017Patents assigned to RES DEV FOUNDATION (5)· patent assignee history
2004–2009Based in Encinitas, CA, US· patent location history
2010–2017Based in San Diego, CA, US· patent location history
2017Patents assigned to GRAY PETER C (1)· patent assignee history
2017Patents assigned to HARRISON CRAIG A (1)· patent assignee history
2017Patents assigned to VALE WYLIE (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| RES DEV FOUNDATION | 5 | 2004–2017 |
| GRAY PETER Cself | 1 | 2017 |
| HARRISON CRAIG A | 1 | 2017 |
| VALE WYLIE | 1 | 2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Encinitas, California, US | 3 | 2004–2009 |
| San Diego, California, US | 2 | 2010–2017 |